Susan Kalled - 17 Feb 2022 Form 4 Insider Report for Compass Therapeutics, Inc. (CMPX)

Role
Chief Scientific Officer
Signature
/s/ Susan Kalled
Issuer symbol
CMPX
Transactions as of
17 Feb 2022
Net transactions value
$0
Form type
4
Filing time
18 Feb 2022, 17:55:43 UTC
Next filing
23 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMPX Stock Option (Right to Buy) Award $0 +60,000 $0.000000 60,000 17 Feb 2022 Common Stock 60,000 $2.52 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest over 48 substantially equal monthly installments starting 03/17/2022